Kezar Life Sciences Inc —— 季度现金流量表 (NASDAQ:KZR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 144.68 M125.26 M109.12 M97.73 M76.65 M 负债总额 27.77 M22.19 M17.34 M14.75 M6.57 M 权益总额 116.92 M103.07 M91.79 M82.98 M70.07 M 负债及股东权益总额 144.68 M125.26 M109.12 M97.73 M76.65 M 总债务 10.33 M9.09 M7.92 M6.65 M0 净债务 -121.92 M-105.27 M-92.93 M-83.56 M-71.88 M

新闻

Enodia acquires Kezar’s Sec61 program assets for $127M potential

Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know

Kezar Life Sciences宣布裁员作为重组计划的一部分

Kezar Life Sciences announces workforce reduction as part of restructuring

Kezar公司的AIH药物在减少类固醇使用方面显示出前景，试验数据揭示

Kezar’s AIH drug shows promise in steroid reduction, trial data reveals

Kezar Life Sciences偿还630万美元贷款并终止与Oxford Finance的协议

Kezar Life Sciences repays $6.3 million loan and ends agreement with Oxford Finance

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.52%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.52%

Kezar Launches Review After FDA Blocks Liver Drug Plans - Kezar Life Sciences (NASDAQ:KZR)

This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Booz Allen Hamilton (NYSE:BAH), AST SpaceMobile (NASDAQ:ASTS)